Immunohistochemical expression of CYP11A1, CYP11B, CYP17, and HSD3B2 in functional and nonfunctional canine adrenocortical tumors
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.17212 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Frederik Allan and 2 co-authors. Institution: Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, Hertfordshire, United Kingdom. Major MEDLINE topics: Dog Diseases, Adrenal Cortex Neoplasms, Steroid 17-alpha-Hydroxylase, Progesterone Reductase. Cited 2 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Functionality of human adrenal tumors is inferred by CYP11B1 (cortisol synthase) expression, CYP11B2 (aldosterone synthase) expression, or both. Hypothesis/Objectives Nonfunctional canine adrenal tumors have low expression of steroidogenic enzymes, whereas aldosterone-producing tumors express CYP11B, and cortisol-producing tumors express both CYP11B and CYP17. Animals Twenty-two client-owned dogs with adrenocortical tumors (ACT) (8 nonfunctional, 7-cortisol producing, 2 aldosterone-producing and 5 functional noncortisol producing) and 2 dogs with normal adrenal glands.
Methods
Retrospective case series. Adrenal functionality was determined from clinical signs and endocrine testing. CYP11A1, CYP11B, CYP17, and HSD3B2 expression was detected by immunohistochemistry on formalin-fixed paraffin-embedded adrenal tissue. Protein expression was semiquantified by 2 blinded observers using H-scoring (results reported as median [range]) and compared in nonfunctional and cortisol-producing adrenal tumors by Mann-Whitney U tests.
Results
CYP11A1, CYP11B, and HSD3B2 were present within all cortical layers of normal adrenal glands, and CYP17 was expressed within the zona fasciculata and zona reticularis. Expression of CYP11A1 (191.25 [97.5-270] vs. 175 [102.5-295] P = .69), CYP11B (190 [130-265] vs. 147.5 [95-202.5]; P = .07), CYP17 (177.5 [87.5-240] vs. 247.5 [55-292.5]; P = .40), and HSD3B2 (230 [47.5-295] vs. 277.5 [67.5-295]; P = .34) were not significantly different between cortisol-producing and nonfunctional ACT. Conclusions and Clinical Importance Our findings suggest it is not possible to determine functionality of canine ACT by immunohistochemistry for steroidogenic enzymes. Tumor size cannot be used to infer functionality of adrenal tumors.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, Hertfordshire, United Kingdom.
ORCID profiles: Frederik Allan, Alice H Watson, Harriet M Syme
Cite
APA
Allan, F., Watson, A. H., & Syme, H. M. (2024). Immunohistochemical expression of CYP11A1, CYP11B, CYP17, and HSD3B2 in functional and nonfunctional canine adrenocortical tumors. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17212
Vancouver
Allan F, Watson AH, Syme HM. Immunohistochemical expression of CYP11A1, CYP11B, CYP17, and HSD3B2 in functional and nonfunctional canine adrenocortical tumors. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17212
BibTeX
@article{Allan2024,
author = {Allan, Frederik and Watson, Alice H and Syme, Harriet M},
title = {Immunohistochemical expression of CYP11A1, CYP11B, CYP17, and HSD3B2 in functional and nonfunctional canine adrenocortical tumors},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.17212}
}
EUVIMED